Delisting riskPopularity #4,375
Jasper Therapeutics (JSPR)
Develops complement inhibitors and targeted antibodies for immunological disorders.
$0.5937
vs last close−0.03 (−4.69%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 47 days
EPS estimate
−$0.08
Revenue estimate
$12.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.62−$1.41−$1.74−$1.13−$0.32−$0.04−$0.10Pending
Estimate−$1.27−$1.17−$1.20−$1.01−$0.79−$0.46−$0.27−$0.08
Surprise−27.6%−20.5%−45.0%−11.9%+59.5%+91.3%+62.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.2M——————Pending
Estimate———————$12.0M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.46 | — | — |
| Sep 2028 | −$0.46 | — | — |
| Jun 2028 | −$0.46 | — | — |
| Mar 2028 | −$0.45 | — | — |
| Dec 2027 | −$0.04 | — | — |
| Sep 2027 | −$0.04 | — | — |
| Jun 2027 | −$0.03 | — | — |
| Mar 2027 | −$0.03 | — | — |
| Dec 2026 | −$0.44 | — | — |
| Nov 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.27 | −$0.10 | +62.7% |
| May 2026 | −$0.46 | −$0.04 | +91.3% |
| Mar 2026 | −$0.79 | −$0.32 | +59.5% |
| Nov 2025 | −$1.01 | −$1.13 | −11.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.46 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.46 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.46 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.45 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.04 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.04 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.03 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.03 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.44 | — | — | $0 | — | — | — |
| Nov 9, 2026 | −$0.08 | — | — | $12.0M | — | — | — |
| Aug 14, 2026 | −$0.27 | −$0.10 | +62.7% | — | — | — | −8.5% |
| May 14, 2026 | −$0.46 | −$0.04 | +91.3% | — | — | — | +4.2% |
| Mar 30, 2026 | −$0.79 | −$0.32 | +59.5% | — | — | — | −14.3% |
| Nov 10, 2025 | −$1.01 | −$1.13 | −11.9% | — | — | — | 0.0% |
| Aug 13, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 4, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 20, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 24, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 14, 2020 |